معرفی
Åsa Hellberg is a Researcher at Lund University's Division of Hematology and Clinical Immunology, affiliated with Transfusion Medicine and the national StemTherapy initiative. Her work focuses on blood group genomics, immunohematology, and molecular diagnostics.
- Division of Hematology and Clinical Immunology, Lund University
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy
Research Interests: Åsa's research bridges hematology, molecular biology, and transfusion medicine. Key areas include:
- Blood group antigen genotyping and phenotyping
- Molecular mechanisms of weak/discrepant blood group expression
- Noninvasive prenatal testing for fetal blood groups
- Transcription factor regulation in blood group systems
- Erythrocyte membrane protein genetics
- EU regulatory frameworks for diagnostic testing
Publication Trends: Her recent articles (2022-2025) emphasize blood group genomics, prenatal diagnostics, and clinical validation of genotyping platforms, with a focus on RH, ABO, and A4GALT gene variants.
Scientific Recognition: Åsa co-received the Vox Sanguinis Best Paper Prize 2018 for her Rh null phenotype research. She actively supervises PhD students including Linn Stenfelt (2016-2020) and contributes to international blood group terminology standardization.
